Global Drivers Analysis: The Rapid Evolution of the Intermittent Pneumatic Compression (IPC) Devices Market

The intermittent pneumatic compression (IPC) devices market is positioned for substantial expansion over the coming years, driven by advancements in medical technology and evolving healthcare practices. This overview explores the projected market growth, major players, significant technological trends, and detailed segmentation shaping the future of IPC devices.

Projected Market Growth and Size for IPC Devices by 2030
The IPC devices market is anticipated to experience robust growth, reaching a value of $2.29 billion by 2030. This translates to a compound annual growth rate (CAGR) of 7.8% during the forecast period. The increasing popularity of home-based thrombosis prevention devices, the rising adoption of connected medical compression systems, and the broadening scope of outpatient and homecare models are key factors propelling this growth. Furthermore, heightened attention to preventive vascular healthcare and continuous technological progress in compression therapy are expected to support market expansion. Key trends include the growing use of portable IPC devices, increased home-based deep vein thrombosis (DVT) prevention, integration of smart pressure control technologies, development of sequential compression methods, and an emphasis on improving patient safety and compliance.

Download a free sample of the intermittent pneumatic compression (ipc) devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13460&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Leading Companies Driving the Intermittent Pneumatic Compression Devices Market
Several prominent companies currently dominate the IPC devices market landscape. These include Cardinal Health Inc., Medtronic PLC, Medline Industries LP, B. Braun Melsungen AG, Getinge AB, Arjo AB, Tactile Systems Technology Inc., Encompass Group LLC, Currie Medical Specialties Inc., ManaMed Inc., Bio Compression Systems Inc., Direct Healthcare Group Ltd., Devon Medical Inc., Mego Afek A.C. Ltd., BSN medical GmbH, Compression Therapy UK Limited, Air Relax Inc., Innova Medical Group Inc., Huntleigh Healthcare Ltd., and Smiths Medical International Ltd.
In December 2024, SHS Capital, a private equity firm from Germany focusing on innovative healthcare investments, acquired a majority stake in Medizintechnik Rostock GmbH. This acquisition supports MTR's succession planning and aims to reinforce its core medical technology operations while expanding access to homecare therapies throughout Germany. Medizintechnik Rostock offers home sequential compression devices as part of its compression therapy product portfolio.

Innovative Trends Propelling Growth in the IPC Devices Industry
A significant driver for IPC devices market growth is the focus on technological innovation. Companies are developing intelligent vascular refill-responsive compression systems that optimize blood flow and reduce stasis by personalizing compression cycles based on real-time vascular refill data. These sensor-driven algorithms tailor intermittent compression to patient-specific needs, enhancing therapeutic effectiveness and improving prevention of venous thromboembolism (VTE).
For example, in November 2024, Cardinal Health launched the Kendall SCD SmartFlow Compression System. This next-generation device features Vascular Refill Detection (VRD) technology combined with a sequential, gradient, circumferential sleeve design. It moves more blood per hour compared to uniform compression systems, offering clinicians a reliable, efficient, and user-friendly solution to prevent VTE and alleviate pain and swelling related to venous stasis.

View the full intermittent pneumatic compression (ipc) devices market report:
https://www.thebusinessresearchcompany.com/report/intermittent-pneumatic-compression-ipc-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Detailed Segmentation of the Intermittent Pneumatic Compression Devices Market
The IPC devices market is divided into several key segments:
1) By Type: Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
2) By Distribution Channel: Clinics, Pharmacies, Online Channels, and Other Offline Channels
3) By Application: Home Use and Hospital Settings
Within the DVT segment, subcategories include Portable DVT Compression Devices, Non-Portable (Stationary) DVT Compression Devices, and Sequential Compression Devices for DVT. Similarly, the PE segment is divided into Portable PE Compression Devices, Non-Portable (Stationary) PE Compression Devices, and Sequential Compression Devices for PE. This segmentation provides a comprehensive view of the market's structure and assists stakeholders in identifying specific opportunities across different product types and distribution methods.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.